2024-02-26
Persistent HIV-1 controllers
Infectiology
In persistent controllers, HIV-1 control is maintained indefinitely in the absence of antiretroviral therapy. In transient controllers, virological control is only temporary. In this study, researchers assessed the HIV-1 reservoir in these two phenotypes to identify factors predicting HIV progression. In both phenotypes, total, intact and defective proviruses were found in lower quantities than in patients on antiretroviral therapy. Intact provirus levels were lower in persistent than in transient controls. The ratio of intact to defective HIV-DNA was significantly higher in transient controls.

Last press reviews
Fibers & Diabetes: is everything equal?

By Ana Espino | Published on september 10, 2025 | 2 min read
Does education really make a difference in lower back pain?

By Ana Espino | Published on september 9, 2025 | 2 min read<br>...
Spinal cord injury & physiotherapy: What does the science say?

By Ana Espino | Published on september 9, 2025 | 2 min read